152 related articles for article (PubMed ID: 28738387)
1. False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.
Koonmee S; Bychkov A; Shuangshoti S; Bhummichitra K; Himakhun W; Karalak A; Rangdaeng S
Acta Cytol; 2017; 61(6):434-440. PubMed ID: 28738387
[TBL] [Abstract][Full Text] [Related]
2. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
3. Detection of false-negative Papanicolaou smears by rapid rescreening in a large routine cervical cytology laboratory.
Wright RG; Halford JA; Ditchmen EJ
Pathology; 1999 Nov; 31(4):379-81. PubMed ID: 10643010
[TBL] [Abstract][Full Text] [Related]
4. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
Marshall CJ; Rowe L; Bentz JS
Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
[TBL] [Abstract][Full Text] [Related]
5. Comparison of false negative rates between 100% rapid review and 10% random full rescreening as internal quality control methods in cervical cytology screening.
Lee BC; Lam SY; Walker T
Acta Cytol; 2009; 53(3):271-6. PubMed ID: 19534266
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
7. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases.
Renshaw AA
Cancer; 1997 Oct; 81(5):264-71. PubMed ID: 9349512
[TBL] [Abstract][Full Text] [Related]
8. Histopathological outcomes of women with abnormal cervical cytology: a review of literature in Thailand.
Kietpeerakool C; Tangjitgamol S; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(16):6489-94. PubMed ID: 25169475
[TBL] [Abstract][Full Text] [Related]
9. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
[TBL] [Abstract][Full Text] [Related]
10. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
11. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
13. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
14. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
Cernescu EC; Anton G; Ruţă S; Cernescu C
Roum Arch Microbiol Immunol; 2013; 72(2):93-104. PubMed ID: 24187808
[TBL] [Abstract][Full Text] [Related]
16. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone.
Renshaw AA
Cancer; 1999 Dec; 87(6):351-3. PubMed ID: 10603188
[TBL] [Abstract][Full Text] [Related]
17. Automation in cytology: a survey conducted by the New Technology Task Force, Papanicolaou Society of Cytopathology.
Masood S; Cajulis RS; Cibas ES; Wilbur DC; Bedrossian CW
Diagn Cytopathol; 1998 Jan; 18(1):47-55. PubMed ID: 9451558
[TBL] [Abstract][Full Text] [Related]
18. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
[TBL] [Abstract][Full Text] [Related]
19. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
20. Quality assessment and improvement of "Unsatisfactory" liquid-based cervicovaginal papanicolaou smears.
Mirzamani N; Chau K; Rafael O; Shergill U; Sajjan S; Sumskaya I; Gimenez C; Klein M; Das K
Diagn Cytopathol; 2017 Oct; 45(10):873-877. PubMed ID: 28752611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]